iPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases

JCI Insight. 2019 Sep 19;4(18):e124299. doi: 10.1172/jci.insight.124299.

Abstract

The control of voluntary skeletal muscle contraction relies on action potentials, which send signals from the motor neuron through the neuromuscular junction (NMJ). Although dysfunction of the NMJ causes various neuromuscular diseases, a reliable in vitro system for disease modeling is currently unavailable. Here, we present a potentially novel 2-step, self-organizing approach for generating in vitro human NMJs from human induced pluripotent stem cells. Our simple and robust approach results in a complex NMJ structure that includes functional connectivity, recapitulating in vivo synapse formation. We used these in vitro NMJs to model the pathological features of spinal muscular atrophy, revealing the developmental and functional defects of NMJ formation and NMJ-dependent muscular contraction. Our differentiation system is therefore useful for investigating and understanding the physiology and pathology of human NMJs.

Keywords: Neuromuscular disease; Neuroscience; Stem cells; iPS cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation
  • Cell Line
  • Gene Knockdown Techniques
  • Humans
  • Induced Pluripotent Stem Cells / physiology
  • Microscopy, Electron
  • Motor Neurons / pathology*
  • Muscle Contraction / physiology*
  • Muscular Atrophy, Spinal / genetics
  • Muscular Atrophy, Spinal / pathology*
  • Muscular Atrophy, Spinal / physiopathology
  • Neuromuscular Junction / genetics
  • Neuromuscular Junction / growth & development
  • Neuromuscular Junction / pathology*
  • Neuromuscular Junction / ultrastructure
  • Optogenetics
  • Proof of Concept Study
  • Survival of Motor Neuron 1 Protein / genetics*

Substances

  • SMN1 protein, human
  • Survival of Motor Neuron 1 Protein